These findings demonstrate that dysregulation of Isx expression and subsequent suppression of Bco1 gene expression constituted the molecular basis for reducing the retinoid biosynthesis from BC in the LRAT-deficient intestine. The gene discussed is ISX; the disease is breast cancer.